Grant of Options, Director/PDMR Dealing
Marechale Capital plc announced the grant of 8,750,000 share options to Directors, a PDMR, and an employee at an exercise price of 4.75 pence per ordinary share, reflecting the closing mid-market price on July 10, 2026. Following this grant, the company will have 24,016,076 options outstanding, representing approximately 9.33% of its current issued share capital of 257,287,255 ordinary shares. The grant to Directors Mark Warde-Norbury, Patrick Booth-Clibborn, and Patrick Claridge is considered a related party transaction, with the independent Director deeming the terms fair and reasonable for shareholders.
Select text to share a quote on X · sign in to keep highlights & notes in your MAC notes
Grant of Options
Director/PDMR Dealing
Marechale Capital plc (AIM: MAC), an established City of London based corporate finance advisory business, developing into a fully integrated digital merchant bank providing corporate finance, capital markets and asset management services underpinned by a technology solutions and distribution platform, announces that it has granted in aggregate 8,750,000 options over ordinary shares of the Company, at an exercise price of 4.75 pence per ordinary share, being the closing mid-market price on 10 July 2026 (the “Share Options") to Directors, a PDMR and an employee of the Company.
Further details of the grant of Share Options are set out in the Notification of Dealing Form below.
| Number of Share Options Granted | Resultant Number of Share Options Held | As a % of Current Issued Share Capital | |
|---|---|---|---|
| Mark Warde-Norbury | 3,000,000 | 4,315,217 | 1.68% |
| Patrick Booth-Clibborn | 3,000,000 | 13,900,859 | 5.40% |
| Patrick Claridge | 1,500,000 | 1,500,000 | 0.58% |
| Nick Cowan | 750,000 | 750,000 | 0.29% |
| Others | 500,000 | 1,450,000 | 0.56% |
| Total | 8,750,000 | 21,916,076 | 8.52% |
The issued share capital of the Company is 257,287,255 ordinary shares. Following the grant of the Share Options, the Company will have 24,016,076 options over ordinary shares in issue representing approximately 9.33 per cent. of the Company’s current issued share capital.
Related Party Transactions
The grant of options to Mark Warde-Norbury, Patrick Booth-Clibborn and Patrick Claridge constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies by virtue of them being Directors of the Company (the “Transaction”). With the exception of Mark Warde-Norbury, Patrick Booth-Clibborn and Patrick Claridge, the Director independent of the Transaction, being Chris Kenning, having consulted with the Company’s nominated adviser, Cairn Financial Advisers LLP, considers that the terms of the Transaction are fair and reasonable insofar as shareholders are concerned.
| 2 | Reason for notification | ||
| a. | Position/Status | Executive Chairman Chief Executive Officer Executive Director PDMR | |
| b. | Initial notification/ Amendment | Initial Notification | |
| a. | Name | Marechale Capital plc | |
| b. | LEI | 2138003NUK6SXCDIAT89 | |
| a. | Description of the financial instrument, type of instrument Identification Code | Grant of Options over Ordinary Shares ISIN: GB0005401087 | |
| b. | Nature of the transaction | Grant of options over ordinary shares | |
| c) | Price(s) and volume(s): | Price(s) per share (p) | Volume(s) |
| 4.75p 4.75p 4.75p 4.75p | 3,000,000 3,000,000 1,500,000 750,000 | ||
| d. | Aggregated information Volume Price | 8,250,000 4.75p | |
| f. | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.